These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36649521)

  • 1. Serum Free Light Chain Reference Intervals in a Local Population in Spain using the Optilite Analyser.
    Rocamonde L; Hermida FJ
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines.
    Morales-García LJ; Pacheco-Delgado MS
    Clin Biochem; 2021 Jun; 92():54-60. PubMed ID: 33662349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study.
    Cotten SW; Shajani-Yi Z; Cervinski MA; Voorhees T; Tuchman SA; Korpi-Steiner N
    Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
    Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
    Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and validation of serum free light chain reference intervals in an ethnic Chinese population.
    Liang YF; Chen WM; Wang QT; Zhai YH; Yang YJ; Liu JY; Levoguer A; Sun WH
    Clin Lab; 2014; 60(2):193-8. PubMed ID: 24660530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications.
    Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS
    Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference Intervals for Plasma Free Kappa and Lambda Chains and Kappa/Lambda Ratio using PENIA.
    Rollborn N; Kultima K; Larsson A
    Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study.
    Long TE; Indridason OS; Palsson R; Rognvaldsson S; Love TJ; Thorsteinsdottir S; Sverrisdottir IS; Vidarsson B; Onundarson PT; Agnarsson BA; Sigurdardottir M; Thorsteinsdottir I; Olafsson I; Thordardottir AR; Eythorsson E; Jonsson A; Gislason G; Olafsson A; Steingrimsdottir H; Hultcrantz M; Durie BGM; Harding S; Landgren O; Kristinsson SY
    Blood Cancer J; 2022 Sep; 12(9):133. PubMed ID: 36100605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
    Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT
    Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
    Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment.
    Morales-García LJ; Lillo Rodríguez RM; Pacheco-Delgado MS
    Clin Biochem; 2023 Aug; 118():110610. PubMed ID: 37429509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum free light chains: diagnostic and prognostic value in multiple myeloma.
    Sthaneshwar P; Nadarajan V; Maniam JA; Nordin N; Gin Gin G
    Clin Chem Lab Med; 2009; 47(9):1101-7. PubMed ID: 19728852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders.
    Vermeersch P; Vercammen M; Holvoet A; Vande Broek I; Delforge M; Bossuyt X
    Clin Chim Acta; 2009 Dec; 410(1-2):54-8. PubMed ID: 19778527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum free light chain reference values: a critical approach.
    Altinier S; Seguso M; Zaninotto M; Varagnolo M; Adami F; Angeli P; Plebani M
    Clin Biochem; 2013 May; 46(7-8):691-3. PubMed ID: 23384536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
    Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
    Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An updated diagnostic range for serum free light chain kappa/lambda ratio using Freelite reagents on BN II or Optilite.
    Li B; King R; Chan B; Rollo C; Thompson S; Florkowski C
    Pathology; 2024 Aug; 56(5):732-734. PubMed ID: 38705800
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
    BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.